Premium
New OBOT program to open in Tennessee in response to COVID‐19
Author(s) -
Knopf Alison
Publication year - 2020
Publication title -
alcoholism and drug abuse weekly
Language(s) - English
Resource type - Journals
eISSN - 1556-7591
pISSN - 1042-1394
DOI - 10.1002/adaw.32759
Subject(s) - covid-19 , environmental science , virology , medicine , outbreak , disease , infectious disease (medical specialty)
Spero Health is opening a new OBOT (office‐based outpatient treatment) center for patients with opioid use disorder (OUD) in Savannah, Tennessee, in response to the high demand for treatment in the COVID‐19 pandemic. This clinic will utilize telehealth and in‐person visit options. Spero Health has more than 35 clinics thro‐ughout Kentucky, Ohio, Indiana and Tennessee, treating more than 7,000 patients a month. Spero Health accepts TennCare, the state's Medicaid plan, and most commercial insurance plans.